Procter & Gamble (NYSE:PG) Stock: Insider Paul Gama Sells 4,331 Shares

Key Points

• CEO Paul Gama sold 4,331 Procter & Gamble shares at an average price of $161.27, generating approximately $698,460. After the sale, he retained 46,793 shares, an 8.47% reduction in his direct holdings.
• Procter & Gamble exceeded quarterly expectations, reporting $2.00 in earnings per share versus the $1.89 consensus estimate and $23.28 billion in revenue, up 4% year over year. The company also declared a quarterly dividend of $1.0885, equivalent to an annualized yield of about 2.7%.
• Analyst sentiment remains generally favorable: PG carries a “Moderate Buy” consensus rating with an average price target of $170.57, although some firms maintain Hold ratings. The stock recently traded near $159.97.

Procter & Gamble Company (The) (NYSE:PG - Get Free Report) CEO Paul Gama sold 4,331 shares of the firm's stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $161.27, for a total transaction of $698,460.37. Following the completion of the sale, the chief executive officer directly owned 46,793 shares in the company, valued at approximately $7,546,307.11. This trade represents a 8.47% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Paul Gama also recently made the following trade(s):

• On Monday, October 5th, Paul Gama sold 2,225 shares of Procter & Gamble stock. The stock was sold at an average price of $145.34, for a total transaction of $323,381.50.

Procter & Gamble Trading Down 0.7%

NYSE:PG traded down $1.05 during mid-day trading on Monday, reaching $159.97. 1,312,726 shares of the company's stock traded hands, compared to its average volume of 9,723,622. The company has a 50 day moving average price of $148.41 and a 200-day moving average price of $147.12. The firm has a market capitalization of $370.76 billion, a price-to-earnings ratio of 24.08, a PEG ratio of 4.00 and a beta of 0.39. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.53. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $167.25.

Procter & Gamble (NYSE:PG - Get Free Report) last released its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 earnings per share for the quarter, topping the consensus estimate of $1.89 by $0.11. The business had revenue of $23.28 billion during the quarter, compared to analysts' expectations of $22.80 billion. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The business's revenue was up 4.0% on a year-over-year basis. During the same quarter last year, the business posted $1.99 EPS. On average, sell-side analysts predict that Procter & Gamble Company will post 6.98 earnings per share for the current year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be paid a $1.0885 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 dividend on an annualized basis and a yield of 2.7%. Procter & Gamble's dividend payout ratio (DPR) is presently 65.51%.

Key Headlines Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Analysts raise targets and ratings: TD Cowen, JPMorgan, BNP Paribas Exane and Citigroup reportedly see meaningful upside for PG, while Freedom Broker upgraded the stock to Buy. The cluster of favorable views may support investor confidence. JPMorgan raises Procter & Gamble price target
• Positive Sentiment: Recent earnings exceeded expectations: Procter & Gamble reported quarterly earnings of $2.00 per share versus the $1.89 consensus estimate, while revenue of $23.28 billion topped expectations of $22.80 billion and increased 4% year over year. These results demonstrate resilient demand across the consumer-staples business. Procter & Gamble earnings report
• Positive Sentiment: Dividend appeal remains supportive: A retirement-focused comparison notes that both PG and Colgate-Palmolive recently raised dividends and exceeded earnings estimates, reinforcing PG’s defensive income-investment case. PG versus Colgate-Palmolive

Institutional Trading of Procter & Gamble

Several institutional investors have recently bought and sold shares of PG. Peterson Wealth Services increased its holdings in shares of Procter & Gamble by 42.8% in the 3rd quarter. Peterson Wealth Services now owns 2,000 shares of the company's stock worth $291,000 after purchasing an additional 599 shares in the last quarter. Motive Wealth Advisors purchased a new position in shares of Procter & Gamble in the third quarter worth $223,000. Leo Wealth LLC bought a new position in shares of Procter & Gamble during the third quarter valued at $673,000. Apollon Wealth Management LLC lifted its holdings in shares of Procter & Gamble by 0.5% during the third quarter. Apollon Wealth Management LLC now owns 100,929 shares of the company's stock valued at $14,663,000 after purchasing an additional 474 shares in the last quarter. Finally, Holos Integrated Wealth LLC boosted its position in shares of Procter & Gamble by 8.7% during the third quarter. Holos Integrated Wealth LLC now owns 1,607 shares of the company's stock valued at $253,000 after buying an additional 129 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on PG shares. Weiss Ratings reissued a "hold (c)" rating on shares of Procter & Gamble in a research report on Monday, September 21st. BNP Paribas Exane raised their target price on shares of Procter & Gamble from $177.00 to $189.00 and gave the stock an "outperform" rating in a research report on Friday. Freedom Broker upgraded shares of Procter & Gamble from a "hold" rating to a "buy" rating and set a $176.00 price target on the stock in a research report on Friday. Wells Fargo & Company boosted their price target on shares of Procter & Gamble from $164.00 to $180.00 and gave the company an "overweight" rating in a research report on Friday. Finally, Argus downgraded shares of Procter & Gamble from a "buy" rating to a "hold" rating in a research note on Friday, August 7th. Fifteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat, Procter & Gamble has an average rating of "Moderate Buy" and a consensus target price of $170.57.

About Procter & Gamble

Procter & Gamble Company NYSE: PG is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company's well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.